INVA

NASD Innoviva, Inc.

Nov 3, 2026 · 12:46 PM ET DELAYED Market Open

$21.01 ↓ -0.01 (-0.05%) Trading Down from the previous close of $21.02, $0.38 below the day’s high of $21.40

YTD change: +5.10%
vs 20-day SMA: -0.05%
vs 200-day SMA: -4.03%

Price ranges

Previous day

$20.89 $21.62

open $21.25 close $21.02

-$0.23 (-1.08%)

Today

$21.01 $21.40

open $21.07 now $21.01

-$0.06 (-0.28%)

Past week

$20.74 $21.65

from $21.05 now $21.01

-$0.04 (-0.19%)

Past month

$20.51 $21.76

from $20.64 now $21.01

+$0.37 (+1.79%)

This year

$19.00 $25.15

from $19.99 now $21.01

+$1.02 (+5.10%)

Price & Performance

-1.97 (-8.57%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good

The stock is 16.4% away from all-time highs of $25.15
INVA is up 5% since the beginning of the year
INVA is up 16% over the past 12 months
INVA is up 2% over the past 1 month
10% of all INVA investors are betting against INVA

INVA reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +16.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-1.14

Earnings momentum +321.4% Quarterly EPS growth

Quarterly change +321.4%

Valuation

P/E ratio 5.16

Enterprise value $1.2B

Beta 0.15

Balance sheet & scale

Income$357.2K

Revenue$453.8M

Cash$579.1M

Debt$269.7K

Income / Debt 1.32×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $1.5B

Innoviva, Inc. engages in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,410.99	-0.46%
JNJ	Johnson & Johnson	$270.56	-0.97%
ABBV	AbbVie, Inc.	$288.84	-2.05%
MRK	Merck & Co., Inc.	$148.36	-0.78%
RHHBY	Roche Holding Ltd Sponsored ADR	$60.67	-0.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.